Vimarsana
Biggest News Aggregation in the World

Listing Application Approved News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Listing Application Approved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Listing Application Approved Today - Breaking & Trending Today

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024 - Vimarsana News

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

Published: April 3, 2024

Company's Listing Application Approved by Nasdaq VICTORIA, BC, April 3, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ; , a clinical-stage biotechnology company leveraging its proprietary...

Source: marketscreener.com
Related Topics:
Eupraxia Pharmaceuticals IncToronto Stock ExchangeCompany Listing ApplicationListing Application ApprovedEupraxia PharmaceuticalsNasdaq Capital MarketRegarding Forward Looking StatementsAlthough Eupraxia
Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024 - Vimarsana News

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

Published: April 3, 2024

/PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its...

Source: prnewswire.com
Related Topics:
Toronto Stock ExchangeCompany Listing ApplicationEupraxia Pharmaceuticals IncListing Application ApprovedEupraxia PharmaceuticalsNasdaq Capital Market